High level expression of many eukaryotic genes is achieved through the action of distal regulatory sequences or enhancers. We have utilized the interaction between the erythroid-specific enhancer in hypersensitivity site 2 (HS2) of the human ␤-globin locus control region and the globin gene promoters as a model to elucidate the mechanisms governing promoter/enhancer interactions. HS2 contains a 400-base pair core element consisting of tandem AP1/NF-E2 motifs flanked by binding sites for multiple ubiquitous and erythroidspecific factors. We have compared the enhancer activity of this core element with a synthetic enhancer lacking the factor binding sites flanking the AP1/NF-E2 motif (HS2 M ). In fetal/erythroid K562 cells, enhancement of a linked ␥-promoter was significantly greater with wild-type HS2 than with HS2 M . In contrast, the increase in ␤-promoter activity in these cells was equivalent with either enhancer fragment. Truncation of the binding site for the fetal/erythroid-specific stage selector protein in the ␥-promoter abolished the additional enhancer activity of HS2. Similarly, insertion of the stage selector protein site into the ␤-promoter boosted enhancer activity observed with HS2 but not HS2 M . In adult erythroid MEL cells, enhancement of a linked ␤-promoter was significantly greater with HS2 than with HS2 M . This effect was dependent on the binding of the adult stage-specific factor, erythroid Kruppel-like factor, to the ␤-promoter. Taken together, this data suggests that the stage-specific factors binding the proximal globin promoters and the factors flanking the AP1/ NF-E2 motif of HS2 act in synergy.
Transcriptional regulation of eukaryotic genes is dependent on the formation of multiprotein complexes on critical cisacting regulatory sequences. Interactions between these proteins can provide tissue and stage-specificity, potential for regulation, and high expression levels (1, 2) . Complexes assembled on adjacent DNA sites exert their influence through cooperative binding and/or transcriptional synergy (3, 4) . In proximal promoter regions, activator proteins are thought to increase the rate of preinitiation complex formation through interactions with their cognate TATA-binding protein-associated factors or other components of the initiation complex (5) (6) (7) (8) (9) (10) (11) . In this setting, the position and arrangement of the factor binding sites is critical for transcriptional activation. The spatial arrangement of factor binding sites within distal enhancer elements is also critical for their function. This is evident in the human interferon-␤ gene enhancer and the T cell receptor-␣ enhancer in which the binding of "architectural proteins" such as LEF-1 and HMG I(Y) induce a change in DNA conformation, allowing the formation of nucleoprotein complexes or enhanceosomes (12, 13) . The coordinate action of these architectural proteins and transcriptional activators such as NFB or ATF-2/c-Jun is essential for optimal enhancer function.
In contrast to this, relatively little is known about the synergistic interactions observed between complexes binding to non-adjacent DNA sites, typified by promoter/enhancer interactions. One current model proposes that initially, DNA looping or bending is required to juxtapose the two elements with subsequent transcriptional activation depending on the efficient recruitment of the enhancer by its preferred promoter (14) . This process may be mediated through direct interaction between an enhancer binding protein(s) and the polymerase complex or indirectly through another protein bound to the proximal promoter (15) (16) (17) . Implicit to this and other models of enhancer action is the need for constraint where only the appropriate gene and not adjacent genes will be activated. This is particularly important in the context of intergenic enhancers, which are capable of activating multiple promoters but opt to activate only one at a given developmental stage. This process may be mediated by the presence of domain elements that demarcate functional units or by promoter selectivity (18 -21) .
The human ␤-globin cluster provides an ideal model for the study of enhancer/promoter interactions in the context of a multigene locus. High level expression from the genes in this locus is dependent on a region containing four erythroid cellspecific and developmentally stable DNase I hypersensitivity sites (HS 1 1-4), the locus control region (LCR) (22) (23) (24) . One of these sites, HS2, contains a powerful erythroid-specific enhancer active in transient transfections, stable cell lines, and transgenic mice (25) (26) (27) (28) . The core of this enhancer consists of tandem binding sites for members of the AP1 family of proteins, including the erythroid-specific factor NF-E2, flanked by consensus sites for multiple ubiquitous and erythroid-specific proteins (29 -33) .
High level developmentally specific expression of the individual globin genes requires the preferential recruitment of the enhancing sequences of the LCR to their respective promoters (34) . We have previously shown that the preferential interaction of HS2 with the ␥-globin gene promoter in fetal/erythroid K562 cells is mediated through the binding of a fetal and erythroid-specific protein complex, the stage selector protein (SSP). This complex is assembled on a sequence immediately adjacent to the TATA box, the stage selector element (SSE) (35, 36) . A second stage-specific factor, erythroid Kruppel-like factor (EKLF) is essential for the preferential expression of the ␤-globin gene in adult erythropoiesis (37) . Mice lacking this protein die in utero of a ␤-thalassemic-like illness (38, 39) .
In the studies reported here, we explore the mechanisms governing enhancer/promoter interactions using HS2 and the ␥-and ␤-globin gene promoters as a paradigm. Our findings reveal that maximal enhancer activity of HS2 in fetal/erythroid K562 cells is dependent on the presence of the SSP binding site in the proximal ␥-promoter. Similarly, EKLF appears integral for the full enhancement of ␤-promoter activity by HS2. Interestingly, these effects appear to depend upon synergistic transcriptional activation between the promoter bound stage-specific proteins and factor binding sites flanking the tandem AP1/NF-E2 element of the enhancer.
EXPERIMENTAL PROCEDURES
DNA Construction-Constructs containing the ␤-globin promoter (Ϫ385-ϩ38) or a hybrid ␤ SSE promoter subcloned 5Ј to the coding sequence of the chloramphenicol acetyltransferase reporter gene (␤CAT, ␤ SSE CAT) and the ␥-promoter (Ϫ260 -ϩ35, Ϫ53-ϩ35, or Ϫ35-ϩ35) subcloned 5Ј of the firefly luciferase gene (␥LUC, Ϫ53␥LUC, Ϫ35␥LUC) have been described previously (26, 36) . Constructs containing the 734-bp HindIII-BglII fragment of HS2 or a synthetic HS2 (HS2 M ), containing the tandem NF-E2/AP-1 core enhancer flanked by neutral DNA to ablate all previously reported co-enhancer footprints but retaining the spacing between the core enhancer and adjacent promoter have been described previously (40) . Briefly, the neutral DNA was designed to be devoid of LCR consensus sequences. The 5Ј component of the neutral DNA consisted of a 169-bp XhoI-HindIII polymerase chain reaction fragment of pBR322 backbone and a 189-bp BglII-SalI fragment of the ampicillin resistance gene. An additional 370-bp BglIISalI polymerase chain reaction fragment of the tetracycline resistance gene was utilized as the 3Ј component.
The XhoI-AatII fragments of the reporter constructs described above were subcloned 3Ј to either HS2 or HS2 M AatII-SalI fragments. HS2 truncation mutants were made by subcloning the 374-bp HindIII-XbaI fragment of HS2 or polymerase chain reaction-generated fragments containing its 5Ј or 3Ј halves upstream of the same neutral DNA fragments used in HS2 M , to once again retain identical spacing to the original 734-bp HS2. These were subcloned 5Ј to ␤CAT and ␤ SSE CAT using the XhoI/SalI-AatII strategy outlined above. HS2 single site mutants, which ablate DNA contacts and disrupt DNA binding of the previously described electrophoretic mobility shift complexes were made using polymerase chain reaction site-directed mutagenesis (31) .
To ensure that the neutral DNA used in these constructs was inactive we performed two control experiments. In the first we replaced the original neutral DNA with totally different neutral DNA and obtained identical results in transfection studies. In the second we linked the neutral fragment to the ␥-promoter and demonstrated no enhancement of activity of this construct compared with the ␥-promoter alone (data not shown).
DNA Transfection and Transient Assays-Plasmid DNA was prepared over double cesium chloride gradients. DNA was transfected into human (K562) or mouse (MEL) erythroleukemia cells by electroporation as described previously (36) . K562 cells were then induced with 20 mM hemin and MEL cells with 2% Me 2 SO. After 48 h, cells were harvested and lysed with Triton X-100 for luciferase assays or repeated freeze-thaw cycles for CAT assays. Luciferase activity was assayed using the Promega system on a Monolight 2001 luminometer (Analytical Luminescence Laboratories), and linearity of the assay was confirmed with serial dilutions. Luciferase lysates had equivalent protein levels. CAT activity was determined as described previously (36) and standardized for lysate protein concentration. Constructs were only compared within the same series of experiments, and the results shown represent at least six different transfections with two independent plasmid preparations. Statistics were calculated using Student's t test; values of p Ͻ 0.05 were considered significant.
Production of Stable Cell Lines-K562 erythroleukemia cells (2 ϫ 10 7 ) were transfected with 10 g of appropriate ␥-promoter vector DNA and 1 g of pCINeo (Promega). Cells were selected in G418 (500 g/ml) for 21 days. Multiple pools were analyzed for luciferase reporter gene expression after 48 h of incubation with hemin. To establish a K562 cell line overexpressing EKLF, these cells were transfected with the eukaryotic expression vector pCIFLAGEKLF, which contains the complete murine cDNA tagged with the FLAG epitope under the control of the viral cytomegalovirus promoter. Cells were selected in G418 (500 g/ml), and clones with the highest level of transgene expression were identified by Western blotting utilizing a specific anti-FLAG antibody and the ECL chemiluminescence system (Amersham).
RESULTS

HS2
Enhancer Activity in K562 Cells-The erythroid-specific enhancer in HS2 has been mapped to a 46-bp element containing a tandem binding site for the AP1 family of proteins (41) . Adjacent to this element (5Ј and 3Ј) are multiple consensus sites for erythroid-specific and ubiquitous transcription factors (YY1, USF, SCL, GATA-1, Sp1) ( Fig. 1 ) (30 -33) . We initially examined the ability of the AP1/NF-E2 binding sites alone or in the presence of the adjacent factor binding sites to enhance expression from the ␥-or ␤-promoter in K562 cells, a model of the fetal erythroid environment (42) . To achieve this we compared the 734-bp HindIII-BglII fragment of HS2, which contained the AP1/NF-E2 element and adjacent sites, to a synthetic HS2 (HS2 M ), which contained the 46-bp element flanked by neutral DNA to retain the spacing between the enhancer and adjacent promoter. Each HS2 fragment was linked to a Ϫ260␥-promoter/luciferase or a Ϫ378␤-promoter/CAT hybrid gene and electroporated into K562 cells. Enhancerless promoter/reporter hybrids served as controls. As shown in Fig. 2 , the addition of the 46-bp AP1/NF-E2 element alone to either the ␥-or ␤-promoter containing construct augmented expression 6-fold (constructs 1 and 2; constructs 4 and 5). This finding is consistent with other studies which have shown that partial enhancer activity is observed in the context of 46-bp element alone (29, 30) . Interestingly, linking the wild-type HS2 to the ␥-promoter construct resulted in an additional 4-fold increase in transcriptional activity to that observed with HS2 M (constructs 2 and 3) (p Ͻ 0.05). In contrast, no further increase in ␤-promoter activity was seen with wild-type HS2, despite the presence of the multiple transcriptional activator sites flanking the 46-bp AP1/NF-E2 element (constructs 5 and 6).
Maximal Enhancer Activity of HS2 Is Dependent on Specific Sequences in the Linked Promoter-The preferential interaction of HS2 with the ␥-promoter in K562 cells is mediated, in part, through binding of the SSP to the SSE (35, 36) . We therefore postulated that the difference in maximal enhancer activity observed with HS2 and HS2 M may also be dependent on the presence of a specific binding site in the promoter. To examine this, we evaluated the effect of truncation mutants of the ␥-promoter on the ability of HS2 or HS2
M to enhance The open boxes represent the binding sites flanking the AP1/ NF-E2 site, with each labeled with its cognate factor. The E, CACC/ SCL, and AT labels represent the erythroid-specific footprint with homology to the Friend virus LTR, the CACC motif footprinted by SCL in adult erythroblasts, and the ubiquitously footprinted AT-rich sequences, respectively. B, the HS2 fragments used were the wild-type sequence (HS2) or the tandem AP1/NF-E2 sites flanked by neutral DNA to retain equivalent spacing (HS2 M ).
expression. As seen in Fig. 3A (constructs 1 and 2) , the differential activity between HS2 and HS2 M was retained with truncation of the ␥-promoter to nucleotide position Ϫ53 relative to the CAP site (p Ͻ 0.001). In contrast, deletion of the SSE (between Ϫ53 and Ϫ35) resulted in diminution of the enhancer activity of the wild-type HS2 to levels not statistically significantly different to those observed with HS2 M (construct 3 and 4). In fact, the reporter gene expression observed with deletion of either the SSE or the sites flanking the AP1/NF-E2 element, or both, was not statistically different (compare construct 2, 3, and 4).
To examine these findings in a genomic context, stable K562 cell lines containing these constructs were derived. As seen in Fig. 3B , the results we had observed in the transient assays were completely reproduced in the stable lines suggesting that maximal response of the ␥-promoter to the HS2 enhancer requires the presence of factors binding adjacent to the AP1/ NF-E2 motifs and the SSE.
To confirm these findings, we linked HS2 or HS2 M to a hybrid ␤-promoter in which the Ϫ53 to Ϫ35 ␤-sequence was replaced by the SSE and transfected these constructs into K562 cells (Fig. 4A) . As seen in Fig. 4B (constructs 1 and 2) , equivalent levels of activity were seen with HS2 and HS2 M linked to the wild-type ␤-promoter. Similar CAT activity was also noted with the hybrid promoter linked to HS2 M (construct 4). In contrast, a significant increase in transcriptional activity was observed with the hybrid ␤-promoter containing the SSE linked to HS2 (construct 3) (p Ͻ 0.01). This observation was not simply attributable to the insertion of a transcriptionally active sequence into the proximal ␤-promoter, as no difference in activity was observed between HS2
M ␤CAT and HS2 M ␤ SSE CAT (compare constructs 2 and 4). Experiments utilizing ␤-promoter and ␤ SSE -promoter containing constructs in stable cell lines yielded similar results (data not shown). These findings confirm that both the SSE and HS2 binding sites flanking the AP1/NF-E2 motif are necessary for maximal enhancement of globin promoters in fetal/erythroid K562 cells.
Multiple Binding Sites Flanking the AP1/NF-E2 Element Are Required for Maximal Enhancer Activity-To determine whether our previous findings were secondary to a direct interaction between an HS2 binding protein and the SSP, we constructed a series of scanning mutants ablating each of the HS2 protein binding sites. These mutants were linked to the hybrid ␤ SSE -promoter and a CAT reporter gene and transfected into K562 cells. Transcriptional activation of the promoter was maintained with mutation of all sites flanking the AP1/NF-E2 element suggesting that no individual site is essential for the synergy observed with the SSE (Table I ). In contrast, mutation of the AP1/NF-E2 binding site substantially reduced the activity of the hybrid promoter (Table I) .
To determine whether combinations of binding sites could be important, we linked a series of 5Ј and 3Ј truncation mutants of HS2 to either the wild-type or hybrid ␤-promoter. In each case, neutral DNA was inserted to retain the original spacing between the AP1/NF-E2 element and the promoter. These constructs were transfected into K562 cells. As shown in Fig. 5 , the 374-bp HindIII-XbaI fragment of HS2 (construct 1) was able to significantly enhance transcriptional activity of the ␤ SSE -promoter. Similarly, with the 5Ј half of the HindIII-XbaI fragment (which contains an erythroid-specific footprint and a Sp1 binding site) or the 3Ј half (which contains the binding sites for GATA-1, USF, SCL, and YY1) significant enhancer activity was observed in the presence of the SSE. These findings suggest that no individual site or combination of sites flanking the AP1/NF-E2 element is absolutely required for enhancer activity.
Maximal HS2 Enhancer-dependent Transcription of the ␤-promoter Is Dependent on Binding of EKLF-The inability of the binding sites flanking the AP1/NF-E2 element to augment ␤-promoter activity in K562 cells coupled with the observation that these sites are essential for high level ␤-gene expression in adult erythroid cells suggested that a developmentally specific protein may also be necessary for maximal enhancer-dependent transcription of the ␤-promoter. To assess this, HS2 or HS2
M was linked to the wild-type ␤-promoter/CAT gene and transfected into the adult erythroid cell line, MEL. An enhancerless ␤-promoter served as a control. As seen in Fig. 6A , reporter gene activity was 5-fold higher with HS2 M than with the promoter alone (constructs 1 and 2). In contrast to the results in K562 cells, an approximate 5-fold enhancement was observed in the presence of the sites flanking the AP1/NF-E2 motif (constructs 2 and 3) (p Ͻ 0.01). To determine whether the adult stage-specific factor EKLF was essential for maximal enhancer activity, we examined the effect of mutating the ␤-promoter CACCC box on the expression of HS2␤CAT and HS2 M ␤CAT in MEL cells. Disruption of the EKLF binding site crippled expression from both promoters to undetectable levels (data not shown). To circumvent this problem, we utilized the observation that significantly higher levels of EKLF are observed in MEL cells than K562 cells (43) . We examined whether maximal HS2 enhancer-dependent transcription of a linked ␤-promoter could be restored in K562 cells overexpressing EKLF (Fig. 6B) . A parental K562 cell line (EKLFϪ) or a line overexpressing EKLF (EKLFϩ) were transfected with HS2␤CAT, HS2 M ␤CAT, or ␤CAT alone (Fig. 6C) . ␤-promoter activity in the absence of the enhancer fragment was increased 2.5-fold in the EKLFϩ line compared with the parental line (Fig. 6C, (1) ). The addition of HS2 M yielded a similar increase in ␤-promoter activity in both parental and EKLF-overexpressing lines (Fig. 6C , compare (1) with (2)). In contrast, the addition of the HS2 fragment containing sites flanking the AP1/ NF-E2 element demonstrated a marked differential effect between the two cell lines, with an 18-fold increase in the EKLFϩ line (Fig. 6C, (3) ) compared with a 4 -6-fold increase in the parental line (Fig. 6C, compare (1) with (3) ). Similar activation was observed in the context of an HS2 fragment in which the CACCC motif had been mutated indicating that binding of EKLF to the enhancer is not required for this effect (data not shown).
DISCUSSION
The studies presented here explore the mechanisms underlying enhancer-dependent transcription of a linked promoter. Utilizing elements in the human ␤-globin locus as a model, we have demonstrated that the maximal activity of HS2 is dependent on the binding of multiple erythroid and ubiquitous factors to the enhancer. It is also dependent on the binding of the erythroidspecific factors EKLF and SSP to the linked globin promoters. By virtue of the restricted expression pattern of these factors, maximal enhancer-dependent activation of the ␤-and ␥-globin promoters is confined to adult or fetal erythroid cell lines, respectively. EKLF and SSP appear to act in synergy with the enhancer-binding proteins flanking the AP1/NF-E2 binding site to maximize the transcriptional activation of the globin promoters by HS2.
Human HS2 represents an ideal element for the study of 
TABLE I
Effect of mutation of footprinted motifs in HS2 on ␤ SSE expression K562 cells were electroporated with plasmids containing the hybrid ␤ SSE promoter linked to the CAT reporter gene 3Ј of a HS2 fragment in which the various footprints had been mutated individually. The expression of these altered HS2-containing constructs was assayed, and activation of the hybrid promoter was corrected with respect to wildtype expression. The asterisk indicates a significant difference from the wild-type sequence (p Ͻ 0.01). enhancer/promoter interactions. Like many enhancers it requires multiple binding motifs within its core to mediate positive effects on expression of linked genes in transfected cells or transgenic mice (30 -32) . As seen in our studies and those of other investigators, the 46-bp element containing the AP1/ NF-E2 binding site is essential for enhancer function and inducibility (26, 31) . However, disruption of the sites flanking the AP1/NF-E2 element reduce enhancer function to varying degrees suggesting that HS2 functions as a multiprotein enhanceosome. Data from our studies, and others, indicate that no single site outside the 46-bp element is critical for enhancer effects as the reduction in activity seen with mutation of footprinted sites are modest (31) (32) (33) . Studies in transgenic mice and MEL cells show that maximal enhancement of ␤-gene expression is only observed in the presence of all binding sites (31, 44 -46) . Replacement of the sites in HS2 that flank the AP1/NF-E2 element with multiple AP1/NF-E2 sites results in dramatic reduction in enhancer activity, suggesting that a specific cooperativity exists between all enhancer binding proteins (31) .
The importance of promoter sequences in transcriptional activation of the ␤-gene by the LCR has been previously demonstrated in MEL cells. These studies identified TATA, CACCC, and CAAT boxes as sequences critical for LCR responsiveness. Although enhanced ␤-gene expression was observed in the presence of the TATA box alone, maximal enhancement was dependent on the presence of all three sites (47) . Our findings suggest that the binding sites for the stage-specific proteins EKLF and SSP in their respective promoters are important for maximal enhancement by HS2. The increase in transcriptional activation observed in the presence of these factors cannot solely be attributed to their binding regulatory sequences, as significant differential effects are observed in the presence or absence of the wild-type enhancer. Truncation of the SSE in the presence of the HS2 M does not alter the level of promoter activity and the addition of this element to the ␤-promoter has no effect in the absence of the fully active HS2. Similarly, the transcriptional activation of the ␤-promoter observed with EKLF expression in K562 cells is markedly different in the presence of the wild-type enhancer. Thus maximal enhancer activity appears to depend on EKLF or SSP and the factors binding to sites adjacent to the AP1/NF-E2 motif.
Although the studies presented here utilize HS2, the studies of Morley et al. (28) indicate that this site alone is sufficient for developmentally specific expression of the human globin genes in transgenic mice. This effect may be due to functional homology between the sites mediated through the conservation of topology of protein binding sites in all human HS and in the corresponding HS in mouse, chicken, and rabbit (48 -50) . Our observations with HS2 may therefore be representative of the interactions between the globin gene promoters and the complete LCR.
Despite the fact that HS2 is situated immediately adjacent to the globin promoters in these and other studies, it appears that this element does not simply function as an extension of the promoter in this context (31) . This is most evident in constructs in which the AP1/NF-E2 site has been mutated and transcriptional activation by the entire enhancer is lost. Similarly, replacement of sites flanking the AP1/NF-E2 motif with alternate transcriptional activator sites significantly reduces promoter enhancement (31) . The effects of the sites flanking the AP1/NF-E2 motif do not appear to be secondary to the topology of the plasmids as results with supercoiled DNA were identical to those observed with linearized plasmids (data not shown). Similarly, the presence of flanking chromatin did not influence cooperative effects of the enhancer bound proteins and EKLF or SSP as stable transfectants reproduced the results we observed in the transient assays (Fig. 3B and data not  shown) .
The mechanisms governing the recruitment of multiprotein enhanceosomes to individual promoters remains unclear. We have recently demonstrated a protein/protein interaction between NF-E2 and hTAF II 130, which allows juxtaposition of the LCR and proximal globin promoters (51) . However, we have been unable to define a similar direct interaction between enhancer-bound proteins outside the AP1/NF-E2 motif and EKLF or SSP, suggesting that the stage-specific transcriptional activation observed with these factors is secondary to a separate mechanism. 2 An alternate hypothesis to explain our findings is that binding of the stage-specific factors to their cognate sites increases the accessibility of the enhancer-bound factors to the transcriptional machinery assembled on the promoter. In support of this is our recent evidence that EKLF interacts with cAMP response element-binding protein, a coactivator putatively involved in chromatin remodeling. 3 Interestingly, mice nullizygous for EKLF demonstrate loss of the hypersensitivity site that forms on the ␤-promoter during definitive erythropoiesis. The EKLF/cAMP response elementbinding protein interaction may result in displacement of core histones allowing recruitment of the basal transcriptional machinery and subsequent interaction between this complex and enhanceosome-bound proteins.
